On the other hand, in our study, obesity was not associated with D2T-PsA (10, 11, 14) despite evidence pointing at a high BMI as an obstacle, lowering the response to treatment with TNF inhibitors (TNFis) (19, 20) and the achievement of remission or minimal disease activity (21, 22). The gene discussed is TNF; the disease is obesity disorder.